![Shaheen Wirk](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Shaheen Wirk
Chief Executive Officer at
Palkon Capital Management LLC
Net worth: 337 969 $ as of 31/07/2026
Profile
Shaheen Wirk is the founder of Palkon Capital Management LLC, serving as Portfolio Manager since 2012.
Current jobs include Director-Medical Alumni Council at Duke University School of Medicine and Independent Director at Movano, Inc. Former jobs include Independent Director at Tvardi Therapeutics, Inc. in 2025 and Director at Tvardi Therapeutics, Inc. (Old) from 2021 to 2025.
Education includes an MBA from The Fuqua School of Business in 2002 and undergraduate, MBA, and doctorate degrees from Duke University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
0.08% | 13/03/2026 | 21,674 ( 0.08% ) | 234 513 $ | 31/07/2026 |
0.53% | 15/04/2025 | 49,265 ( 0.53% ) | 103 457 $ | 31/07/2026 |
Shaheen Wirk active positions
| Companies | Position | Start |
|---|---|---|
Palkon Capital Management LLC
 Palkon Capital Management LLC Investment ManagersFinance Palkon invests in innovative private and public life sciences companies. By investing in development stage healthcare companies, they can simultaneously catalyze innovation that addresses unmet medical needs and capture key value inflections. | Chief Executive Officer | 01/09/2012 |
Duke University School of Medicine
 Duke University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Former positions of Shaheen Wirk
| Companies | Position | End |
|---|---|---|
Tvardi Therapeutics, Inc.
 Tvardi Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel and oral molecule therapies for STAT3 to treat fibrosis-driven diseases | Director/Board Member | 15/04/2025 |
Movano, Inc.
 Movano, Inc. Packaged SoftwareTechnology Services Develops software based non-invasive continuous glucose monitoring devices | Director/Board Member | - |
Training of Shaheen Wirk
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
81
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Palkon Capital Management LLC
Palkon Capital Management LLC Investment ManagersFinance Palkon invests in innovative private and public life sciences companies. By investing in development stage healthcare companies, they can simultaneously catalyze innovation that addresses unmet medical needs and capture key value inflections. | Finance |
The Fuqua School of Business
 The Fuqua School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Duke University School of Medicine
Duke University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tvardi Therapeutics, Inc.
Tvardi Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel and oral molecule therapies for STAT3 to treat fibrosis-driven diseases | Health Technology |
Movano, Inc.
Movano, Inc. Packaged SoftwareTechnology Services Develops software based non-invasive continuous glucose monitoring devices | Technology Services |
- Stock Market
- Insiders
- Shaheen Wirk
